Nea Management Company Boosted Epizyme (EPZM) Position by $3.80 Million; Shares Rose; First Manhattan Company Has Trimmed Its Position in Raytheon (RTN) as Shares Rose

January 19, 2018 - By Adrian Erickson

First Manhattan Company decreased its stake in Raytheon (RTN) by 8.25% based on its latest 2017Q3 regulatory filing with the SEC. First Manhattan Company sold 20,743 shares as the company’s stock rose 4.85% with the market. The hedge fund held 230,599 shares of the industrial machinery and components company at the end of 2017Q3, valued at $43.03 million, down from 251,342 at the end of the previous reported quarter. First Manhattan Company who had been investing in Raytheon for a number of months, seems to be less bullish one the $56.58B market cap company. The stock decreased 0.65% or $1.28 during the last trading session, reaching $195.71. About 1.38M shares traded or 1.47% up from the average. Raytheon Company (NYSE:RTN) has risen 24.03% since January 19, 2017 and is uptrending. It has outperformed by 7.33% the S&P500.

Nea Management Company Llc increased its stake in Epizyme Inc (EPZM) by 3.19% based on its latest 2017Q3 regulatory filing with the SEC. Nea Management Company Llc bought 200,000 shares as the company’s stock rose 39.84% with the market. The institutional investor held 6.46 million shares of the health care company at the end of 2017Q3, valued at $123.08M, up from 6.26M at the end of the previous reported quarter. Nea Management Company Llc who had been investing in Epizyme Inc for a number of months, seems to be bullish on the $1.03 billion market cap company. The stock decreased 0.17% or $0.03 during the last trading session, reaching $14.9. About 378,727 shares traded. Epizyme, Inc. (NASDAQ:EPZM) has risen 91.85% since January 19, 2017 and is uptrending. It has outperformed by 75.15% the S&P500.

Since August 14, 2017, it had 0 insider purchases, and 4 selling transactions for $1.08 million activity. $121,723 worth of Raytheon Company (NYSE:RTN) shares were sold by Jimenez Frank R. 829 Raytheon Company (NYSE:RTN) shares with value of $149,378 were sold by Clark Vernon E. Lawrence Taylor W also sold $690,304 worth of Raytheon Company (NYSE:RTN) on Thursday, August 31.

Analysts await Raytheon Company (NYSE:RTN) to report earnings on January, 25. They expect $2.03 earnings per share, up 7.98% or $0.15 from last year’s $1.88 per share. RTN’s profit will be $586.84M for 24.10 P/E if the $2.03 EPS becomes a reality. After $1.97 actual earnings per share reported by Raytheon Company for the previous quarter, Wall Street now forecasts 3.05% EPS growth.

First Manhattan Company, which manages about $20.51 billion and $17.46B US Long portfolio, upped its stake in Telephone & Data Sys (NYSE:TDS) by 42,784 shares to 147,859 shares, valued at $4.12M in 2017Q3, according to the filing. It also increased its holding in Macerich Co (NYSE:MAC) by 98,725 shares in the quarter, for a total of 107,725 shares, and has risen its stake in Spectrum Brands Hld (NYSE:SPB).

Among 21 analysts covering Raytheon Company (NYSE:RTN), 17 have Buy rating, 1 Sell and 3 Hold. Therefore 81% are positive. Raytheon Company had 70 analyst reports since July 28, 2015 according to SRatingsIntel. Stifel Nicolaus maintained Raytheon Company (NYSE:RTN) rating on Thursday, July 27. Stifel Nicolaus has “Buy” rating and $18500 target. Deutsche Bank maintained the shares of RTN in report on Friday, October 28 with “Hold” rating. The firm has “Buy” rating by Buckingham Research given on Tuesday, October 31. The firm earned “Buy” rating on Friday, July 7 by RBC Capital Markets. The company was maintained on Monday, October 9 by Citigroup. As per Monday, January 8, the company rating was maintained by Stifel Nicolaus. The rating was maintained by Bank of America on Friday, October 27 with “Buy”. Barclays Capital downgraded Raytheon Company (NYSE:RTN) rating on Monday, November 30. Barclays Capital has “Equal-Weight” rating and $125 target. RBC Capital Markets maintained it with “Buy” rating and $209.0 target in Sunday, October 8 report. The firm has “Buy” rating given on Monday, July 17 by Cowen & Co.

Investors sentiment increased to 1.21 in Q3 2017. Its up 0.09, from 1.12 in 2017Q2. It is positive, as 42 investors sold RTN shares while 343 reduced holdings. 118 funds opened positions while 346 raised stakes. 205.51 million shares or 1.55% less from 208.75 million shares in 2017Q2 were reported. Virtus Invest Advisers Incorporated holds 12,821 shares or 0.25% of its portfolio. Whittier Tru holds 0.09% in Raytheon Company (NYSE:RTN) or 13,369 shares. Oakbrook Ltd Liability Company accumulated 19,500 shares or 0.23% of the stock. Usa Fincl Portformulas has invested 0.07% in Raytheon Company (NYSE:RTN). Moreover, Azimuth Capital Mngmt Limited Liability Company has 0.27% invested in Raytheon Company (NYSE:RTN) for 19,569 shares. Pacific Alternative Asset Mgmt Communications Ltd Liability owns 0.47% invested in Raytheon Company (NYSE:RTN) for 23,093 shares. Boston Family Office Limited Liability Corporation has 0.51% invested in Raytheon Company (NYSE:RTN) for 24,231 shares. Community Retail Bank Na, New York-based fund reported 895 shares. Motco reported 0.6% of its portfolio in Raytheon Company (NYSE:RTN). Bbva Compass National Bank holds 0.01% or 1,076 shares in its portfolio. National Pension Service invested in 0.26% or 259,134 shares. Moreover, Swiss Bancshares has 0.25% invested in Raytheon Company (NYSE:RTN). Pekin Singer Strauss Asset Mngmt Il holds 2,784 shares. Rhumbline Advisers has 502,665 shares for 0.2% of their portfolio. 308,507 are held by Atalanta Sosnoff Cap Llc.

Investors sentiment decreased to 1.46 in Q3 2017. Its down 0.47, from 1.93 in 2017Q2. It dropped, as 15 investors sold EPZM shares while 22 reduced holdings. 13 funds opened positions while 41 raised stakes. 58.04 million shares or 22.28% more from 47.46 million shares in 2017Q2 were reported. Citigroup Incorporated stated it has 0% in Epizyme, Inc. (NASDAQ:EPZM). Rhumbline Advisers accumulated 50,620 shares. Woodstock stated it has 0.12% of its portfolio in Epizyme, Inc. (NASDAQ:EPZM). Great West Life Assurance Com Can, a Manitoba – Canada-based fund reported 4,800 shares. State Common Retirement Fund holds 46,600 shares or 0% of its portfolio. Hanseatic Mngmt Services Inc holds 47 shares or 0% of its portfolio. Schwab Charles Investment Mgmt holds 217,168 shares. Amer Group Incorporated Inc stated it has 27,664 shares or 0% of all its holdings. Hbk Invests Limited Partnership accumulated 0% or 11,600 shares. Ubs Asset Americas stated it has 0% in Epizyme, Inc. (NASDAQ:EPZM). Invesco Ltd stated it has 405,513 shares or 0% of all its holdings. Moreover, First Republic Invest Mngmt has 0% invested in Epizyme, Inc. (NASDAQ:EPZM) for 14,243 shares. The New York-based Secor Capital Advsr Ltd Partnership has invested 0.13% in Epizyme, Inc. (NASDAQ:EPZM). Lord Abbett Company Ltd Company invested 0.04% in Epizyme, Inc. (NASDAQ:EPZM). Bain Public Equity Mgmt Limited Company holds 0.22% or 180,574 shares.

Since August 24, 2017, it had 1 insider purchase, and 3 insider sales for $2.32 million activity. $235,266 worth of Epizyme, Inc. (NASDAQ:EPZM) was sold by Ho Peter Tai-Ching on Thursday, August 24.

Among 12 analysts covering Epizyme (NASDAQ:EPZM), 11 have Buy rating, 0 Sell and 1 Hold. Therefore 92% are positive. Epizyme had 29 analyst reports since August 6, 2015 according to SRatingsIntel. Mizuho maintained it with “Buy” rating and $18 target in Tuesday, May 10 report. The stock of Epizyme, Inc. (NASDAQ:EPZM) earned “Buy” rating by Oppenheimer on Monday, July 24. On Thursday, November 2 the stock rating was downgraded by RBC Capital Markets to “Sector Perform”. Cowen & Co maintained the stock with “Buy” rating in Wednesday, June 7 report. The company was maintained on Friday, August 4 by RBC Capital Markets. The rating was maintained by H.C. Wainwright with “Buy” on Wednesday, June 7. RBC Capital Markets maintained Epizyme, Inc. (NASDAQ:EPZM) on Monday, June 12 with “Buy” rating. Oppenheimer maintained the shares of EPZM in report on Wednesday, June 21 with “Buy” rating. The rating was maintained by RBC Capital Markets with “Outperform” on Monday, September 28. The rating was maintained by SunTrust on Friday, October 27 with “Buy”.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>